Clinical Trials · NCT06257966
A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin
- Phase
- Phase 3
- Recruitment status
- Active Not Recruiting
- Sponsor
- Beijing Dongfang Biotech Co., Ltd.
- Enrollment
- 600
- Start date
- Jul 2024
- Locations
- 1 site, China
- Primary endpoint
- HbA1c